149 related articles for article (PubMed ID: 17012257)
1. Detection of novel intracellular alpha-synuclein oligomeric species by fluorescence lifetime imaging.
Klucken J; Outeiro TF; Nguyen P; McLean PJ; Hyman BT
FASEB J; 2006 Oct; 20(12):2050-7. PubMed ID: 17012257
[TBL] [Abstract][Full Text] [Related]
2. A single amino acid substitution differentiates Hsp70-dependent effects on alpha-synuclein degradation and toxicity.
Klucken J; Shin Y; Hyman BT; McLean PJ
Biochem Biophys Res Commun; 2004 Dec; 325(1):367-73. PubMed ID: 15522241
[TBL] [Abstract][Full Text] [Related]
3. Accumulation and clearance of alpha-synuclein aggregates demonstrated by time-lapse imaging.
Opazo F; Krenz A; Heermann S; Schulz JB; Falkenburger BH
J Neurochem; 2008 Jul; 106(2):529-40. PubMed ID: 18410502
[TBL] [Abstract][Full Text] [Related]
4. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease.
Auluck PK; Chan HY; Trojanowski JQ; Lee VM; Bonini NM
Science; 2002 Feb; 295(5556):865-8. PubMed ID: 11823645
[TBL] [Abstract][Full Text] [Related]
5. Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro.
McLean PJ; Klucken J; Shin Y; Hyman BT
Biochem Biophys Res Commun; 2004 Aug; 321(3):665-9. PubMed ID: 15358157
[TBL] [Abstract][Full Text] [Related]
6. Raised calcium promotes α-synuclein aggregate formation.
Nath S; Goodwin J; Engelborghs Y; Pountney DL
Mol Cell Neurosci; 2011 Feb; 46(2):516-26. PubMed ID: 21145971
[TBL] [Abstract][Full Text] [Related]
7. Hsp70 molecular chaperones and Parkinson's disease.
Witt SN
Biopolymers; 2010 Mar; 93(3):218-28. PubMed ID: 19768775
[TBL] [Abstract][Full Text] [Related]
8. Impairment of redox state and dopamine level induced by alpha-synuclein aggregation and the prevention effect of hsp70.
Yu F; Xu H; Zhuo M; Sun L; Dong A; Liu X
Biochem Biophys Res Commun; 2005 May; 331(1):278-84. PubMed ID: 15845390
[TBL] [Abstract][Full Text] [Related]
9. DnaK/DnaJ/GrpE of Hsp70 system have differing effects on alpha-synuclein fibrillation involved in Parkinson's disease.
Ahmad A
Int J Biol Macromol; 2010 Mar; 46(2):275-9. PubMed ID: 20060408
[TBL] [Abstract][Full Text] [Related]
10. Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity.
Wang X; Moualla D; Wright JA; Brown DR
J Neurochem; 2010 May; 113(3):704-14. PubMed ID: 20141569
[TBL] [Abstract][Full Text] [Related]
11. Dopamine-induced conformational changes in alpha-synuclein.
Outeiro TF; Klucken J; Bercury K; Tetzlaff J; Putcha P; Oliveira LM; Quintas A; McLean PJ; Hyman BT
PLoS One; 2009 Sep; 4(9):e6906. PubMed ID: 19730729
[TBL] [Abstract][Full Text] [Related]
12. FLZ Attenuates α-Synuclein-Induced Neurotoxicity by Activating Heat Shock Protein 70.
Bao XQ; Wang XL; Zhang D
Mol Neurobiol; 2017 Jan; 54(1):349-361. PubMed ID: 26742515
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 70 inhibits alpha-synuclein fibril formation via interactions with diverse intermediates.
Huang C; Cheng H; Hao S; Zhou H; Zhang X; Gao J; Sun QH; Hu H; Wang CC
J Mol Biol; 2006 Dec; 364(3):323-36. PubMed ID: 17010992
[TBL] [Abstract][Full Text] [Related]
14. Structural changes in alpha-synuclein affect its chaperone-like activity in vitro.
Kim TD; Paik SR; Yang CH; Kim J
Protein Sci; 2000 Dec; 9(12):2489-96. PubMed ID: 11206070
[TBL] [Abstract][Full Text] [Related]
15. Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins.
Schnack C; Danzer KM; Hengerer B; Gillardon F
Neuroscience; 2008 Jul; 154(4):1450-7. PubMed ID: 18541383
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity.
Rekas A; Adda CG; Andrew Aquilina J; Barnham KJ; Sunde M; Galatis D; Williamson NA; Masters CL; Anders RF; Robinson CV; Cappai R; Carver JA
J Mol Biol; 2004 Jul; 340(5):1167-83. PubMed ID: 15236975
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence imaging of amyloid formation in living cells by a functional, tetracysteine-tagged alpha-synuclein.
Roberti MJ; Bertoncini CW; Klement R; Jares-Erijman EA; Jovin TM
Nat Methods; 2007 Apr; 4(4):345-51. PubMed ID: 17351621
[TBL] [Abstract][Full Text] [Related]
18. The aggregation and fibrillation of alpha-synuclein.
Fink AL
Acc Chem Res; 2006 Sep; 39(9):628-34. PubMed ID: 16981679
[TBL] [Abstract][Full Text] [Related]
19. Formation of toxic oligomeric alpha-synuclein species in living cells.
Outeiro TF; Putcha P; Tetzlaff JE; Spoelgen R; Koker M; Carvalho F; Hyman BT; McLean PJ
PLoS One; 2008 Apr; 3(4):e1867. PubMed ID: 18382657
[TBL] [Abstract][Full Text] [Related]
20. Unique copper-induced oligomers mediate alpha-synuclein toxicity.
Wright JA; Wang X; Brown DR
FASEB J; 2009 Aug; 23(8):2384-93. PubMed ID: 19325037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
